Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Posted on: Wednesday, 10 December 2008, 09:03 CST
The Board of Directors today also declared a quarterly dividend of
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in
SOURCE Schering-Plough Corporation
Source: PR Newswire
Related Articles
- Schering-Plough Reports Financial Results for 2009 Third Quarter
- Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings
- Schering-Plough Reports Financial Results for 2009 Second Quarter
- Schering-Plough Schedules Conference Call Webcast for 2009 Second Quarter Earnings
- New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
- Schering-Plough Reports Financial Results for 2009 First Quarter
- EPA Names Schering-Plough 2009 EPA ENERGY STAR(R) Partner of the Year
- Schering-Plough Schedules Conference Call Webcast for 2009 First Quarter Earnings
- Schering-Plough Selects Benefit Advocates for Health Advocacy
- Pfizer Animal Health Enters into Agreement to Acquire Animal Health Products From Schering-Plough
User Comments (0)

RSS Feeds